304 related articles for article (PubMed ID: 31763466)
1. Daidzein cocrystals: An opportunity to improve its biopharmaceutical parameters.
Bhalla Y; Chadha K; Chadha R; Karan M
Heliyon; 2019 Nov; 5(11):e02669. PubMed ID: 31763466
[TBL] [Abstract][Full Text] [Related]
2. Engineering a Remedy to Modulate and Optimize Biopharmaceutical Properties of Rebamipide by Synthesizing New Cocrystal: In Silico and Experimental Studies.
Jindal A; Singh R; Tomar S; Dureja J; Karan M; Chadha R
Pharm Res; 2021 Dec; 38(12):2129-2145. PubMed ID: 34904202
[TBL] [Abstract][Full Text] [Related]
3. Novel Aceclofenac Cocrystals with l-Cystine: Virtual Coformer Screening, Mechanochemical Synthesis, and Physicochemical Investigations.
Kumar S; Gupta A; Prasad R; Singh S
Curr Drug Deliv; 2021; 18(1):88-100. PubMed ID: 32807053
[TBL] [Abstract][Full Text] [Related]
4. Cocrystals of diacerein: Towards the development of improved biopharmaceutical parameters.
Tomar S; Chakraborti S; Jindal A; Grewal MK; Chadha R
Int J Pharm; 2020 Jan; 574():118942. PubMed ID: 31830577
[TBL] [Abstract][Full Text] [Related]
5. Chrysin cocrystals: Characterization and evaluation.
Chadha R; Bhalla Y; Nandan A; Chadha K; Karan M
J Pharm Biomed Anal; 2017 Feb; 134():361-371. PubMed ID: 27894779
[TBL] [Abstract][Full Text] [Related]
6. Supramolecular Cocrystals of Gliclazide: Synthesis, Characterization and Evaluation.
Chadha R; Rani D; Goyal P
Pharm Res; 2017 Mar; 34(3):552-563. PubMed ID: 28035627
[TBL] [Abstract][Full Text] [Related]
7. Novel Aceclofenac-l-Cystine and Aceclofenac-Urea Cocrystals with Enhanced Oral Bioavailability.
Kumar S; Gupta A; Mishra CK; Singh S
Curr Drug Deliv; 2021; 18(8):1174-1181. PubMed ID: 33602085
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.
Panzade P; Shendarkar G; Shaikh S; Balmukund Rathi P
Adv Pharm Bull; 2017 Sep; 7(3):399-408. PubMed ID: 29071222
[No Abstract] [Full Text] [Related]
9. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
[TBL] [Abstract][Full Text] [Related]
10. Effect of Coformer Selection on In Vitro and In Vivo Performance of Adefovir Dipivoxil Cocrystals.
Li L; Pang Z; Ma K; Gao Y; Zheng D; Wei Y; Zhang J; Qian S
Pharm Res; 2021 Oct; 38(10):1777-1791. PubMed ID: 34729701
[TBL] [Abstract][Full Text] [Related]
11. Isostructural cocrystals of metaxalone with improved dissolution characteristics.
Gohel SK; Palanisamy V; Sanphui P; Prakash M; Singh GP; Chernyshev V
RSC Adv; 2021 Sep; 11(49):30689-30700. PubMed ID: 35479860
[TBL] [Abstract][Full Text] [Related]
12. The effects of pH, surfactant, ion concentration, coformer, and molecular arrangement on the solubility behavior of myricetin cocrystals.
Ren S; Liu M; Hong C; Li G; Sun J; Wang J; Zhang L; Xie Y
Acta Pharm Sin B; 2019 Jan; 9(1):59-73. PubMed ID: 30766778
[TBL] [Abstract][Full Text] [Related]
13. Cocrystal Construction Between Rosuvastatin Calcium and L-asparagine with Enhanced Solubility and Dissolution Rate.
Vemuri VD; Lankalapalli S
Turk J Pharm Sci; 2021 Dec; 18(6):790-798. PubMed ID: 34979738
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of binding with the α-glucosidase in vitro and the evaluation on hypoglycemic effect in vivo: Cocrystals involving synergism of gallic acid and conformer.
Xue N; He B; Jia Y; Yang C; Wang J; Li M
Eur J Pharm Biopharm; 2020 Nov; 156():64-74. PubMed ID: 32890659
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical Cocrystal: A Novel Approach to Tailor the Biopharmaceutical Properties of a Poorly Water Soluble Drug.
Srivastava D; Fatima Z; Kaur CD; Tulsankar SL; Nashik SS; Rizvi DA
Recent Pat Drug Deliv Formul; 2019; 13(1):62-69. PubMed ID: 30848223
[TBL] [Abstract][Full Text] [Related]
16. Superior Solubility and Dissolution of Zaltoprofen via Pharmaceutical Cocrystals.
Panzade P; Shendarkar G
Turk J Pharm Sci; 2019 Sep; 16(3):310-316. PubMed ID: 32454729
[TBL] [Abstract][Full Text] [Related]
17. Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.
Sathisaran I; Dalvi SV
Pharmaceutics; 2018 Jul; 10(3):. PubMed ID: 30065221
[TBL] [Abstract][Full Text] [Related]
18. Implication of Coformer Structural Diversity on Cocrystallization Outcomes of Telmisartan with Improved Biopharmaceutical Performance.
Haneef J; Arora P; Chadha R
AAPS PharmSciTech; 2019 Dec; 21(1):10. PubMed ID: 31802267
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
Basavoju S; Boström D; Velaga SP
Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
[TBL] [Abstract][Full Text] [Related]
20. Dissolution Enhancement of Atorvastatin Calcium by Cocrystallization.
Al-Kazemi R; Al-Basarah Y; Nada A
Adv Pharm Bull; 2019 Oct; 9(4):559-570. PubMed ID: 31857959
[No Abstract] [Full Text] [Related]
[Next] [New Search]
